Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Medifast assumes no obligation to update any ... These products and associated meal plans are specifically designed for those on GLP-1 medications. We also plan to simultaneously launch a ...

The word "diet" can refer to the eating plan a person follows on such a program ... vice president of scientific and clinical affairs at Medifast, the parent company of Optavia, tells TODAY.com.

Detailed price information for Weight Watchers International Inc (WW-Q) from The Globe and Mail including charting and trades.

Medifast Inc (NYSE:MED) plans to launch new products under the Optavia Ascend brand, specifically designed for those on GLP-1 medications, in early 2025. The company maintains a strong balance ...

Medifast reported better-than-expected quarterly ... The company's stock repurchase plan and significant cash reserves indicate confidence in future growth, with a potential valuation target ...

Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what investors should know. Medifast missed analysts’ revenue expectations by 3.2% last ...

Medifast ( (MED)) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: MED) is a health and wellness company known for its ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Monday reported profit of $1.1 million in its third quarter. On a per-share basis, the Baltimore-based company said it had profit of 10 ...

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers ...

With declining lithium prices leading to reduced 2025 operating costs and capex, here’s what we think of Albemarle stock. Maintaining independence and editorial freedom is essential to our ...